| Miss Casey Newell Ray, PHARMD | |
|
2543 John Hawkins Pkwy, Hoover, AL 35244-3533 | |
| (205) 982-8519 | |
| Not Available |
| Full Name | Miss Casey Newell Ray |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2543 John Hawkins Pkwy, Hoover, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801178587 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 16310 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Casey Newell Ray, PHARMD 1417 Haddon Pl, Hoover, AL 35226-6306 Ph: (205) 960-5234 | Miss Casey Newell Ray, PHARMD 2543 John Hawkins Pkwy, Hoover, AL 35244-3533 Ph: (205) 982-8519 |
News Archive
Thirteen pharmaceutical companies; the governments of the U.S., U.K. and United Arab Emirates; the Bill & Melinda Gates Foundation; the WHO; the World Bank; the Drugs for Neglected Diseases initiative (DNDi); and other global health organizations "announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade," according to a press release from Global Health Strategies.
The US Food and Drug Administration (FDA) approved Tekamlo™ (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna® (aliskiren), with the widely used calcium channel blocker amlodipine. Tekamlo is approved as initial therapy for patients who are likely to need multiple drugs to achieve their blood pressure goals, and as replacement therapy for patients whose blood pressure is not adequately controlled with either aliskiren or amlodipine alone.
An international team of researchers led by Yale University, University of Iowa, and the Translational Genomics Research Institute, an affiliate of City of Hope, has discovered a new pathway that may improve success against an incurable type of children's brain cancer.
Merck Sharp & Dohme Limited (MSD) announced today that ISENTRESS® (raltegravir) has been granted an expanded licence from the European Union Commission (Commission) for use in combination with other antiretroviral (ARV) medicinal products for the treatment of HIV-1 infection in adult patients, including adult patients starting HIV-1 therapy for the first time (treatment-naïve), as well as treatment-experienced adult patients.
Researchers have gained new insight into the mechanisms involved in how skeletal muscles lose their mass and strength as people age, called sarcopenia.
› Verified 9 days ago
Megan Elizabeth Monroe, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1584 Montgomery Hwy, Hoover, AL 35216 Phone: 205-824-7223 | |
Dr. Katherine Hunter, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1584 Montgomery Hwy, Hoover, AL 35216 Phone: 205-824-7223 | |
Dr. Laura Smelcer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5188 Caldwell Mill Rd, Hoover, AL 35244 Phone: 205-980-7511 Fax: 205-980-7510 | |
William L Box, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1915 Hoover Ct, Hoover, AL 35226 Phone: 205-822-1151 Fax: 205-822-1183 | |
Nicole Gafford, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5346 Stadium Trace Pkwy, Hoover, AL 35244 Phone: 205-682-8078 | |
Mayank Modi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2780 John Hawkins Pkwy, Hoover, AL 35244 Phone: 205-733-0055 | |
Amy Yates Mills, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2505 Highway 150, Hoover, AL 35244 Phone: 205-982-9696 Fax: 205-982-7824 |